EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Effects of Two Rg3-Enriched Korean Ginseng Preparations on Blood Pressure in Adults with Early-Stage Hypertension: A Randomized, Double-Blind, Placebo-Controlled Trial

Jin-Hwan Oh, Yoo-Seok Cheong, Seong-Hoon Lim, Seong Lee, Jin-Hee Kim, Hyuna Jang iD, Youl Hour, Vladimir Vuksan iD, Hyang-Im Baek iD

Nutrients · 2026

DOI: 10.3390/nu18203448 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Nutrients, 2026. Verfasst von Jin-Hwan Oh und 8 weiteren Autor:innen. Beteiligte Einrichtung: BTGin Co., Ltd., Daejeon 34024, Republic of Korea. Hauptthemen laut MEDLINE: Panax, Ginsenosides, Hypertension, Blood Pressure. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Agriculture, Food and Rural Affairs, Korea Food Research Institute, BTGin Co., Ltd..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Ginsenoside Rg3, a bioactive component of processed Korean ginseng, has demonstrated vasodilatory and blood pressure-lowering effects; however, clinical evidence on the long-term effects of Rg3-enriched ginseng preparations remains limited. This study evaluated the effects of two differently processed Rg3-enriched Korean ginseng preparations on blood pressure in adults with early-stage hypertension.

Methods

In this 12-week, randomized, double-blind, placebo-controlled trial, 90 adults were randomly assigned to vitamin C-treated white ginseng (VTWG), enzyme-treated red ginseng (ETRG), or placebo (n = 30 per group). Both interventions provided approximately 40 mg/day of Rg3. Changes in systolic blood pressure (SBP) and diastolic blood pressure (DBP) were primary outcomes.

Results

From baseline to week 12, SBP decreased by 7.27 ± 6.15 mmHg in the VTWG group and 9.86 ± 6.47 mmHg in the ETRG group, whereas it increased by 5.03 ± 6.52 mmHg in the placebo group (both adjusted p < 0.0001 vs. placebo). DBP decreased by 5.27 ± 5.58 and 6.32 ± 5.55 mmHg in the VTWG and ETRG groups, respectively, compared with a decrease of 0.90 ± 6.31 mmHg in the placebo group (adjusted p = 0.006, 0.0006, respectively). MAP also decreased significantly in both intervention groups compared with placebo (both adjusted p < 0.0001), whereas NO changes differed significantly only between ETRG and placebo (adjusted p = 0.017). No clinically meaningful safety concerns were identified.

Conclusions

Twelve-week supplementation with either Rg3-enriched Korean ginseng preparation significantly reduced blood pressure compared with placebo, suggesting potential benefits for blood pressure management in adults with early-stage hypertension.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PanaxGinsenosidesHypertensionBlood PressureAntihypertensive AgentsPlant ExtractsHumansDouble-Blind MethodMiddle AgedFemaleMaleAdult

Stichwörter der Autor:innen

Korean red ginsengKorean white ginsengPanax ginsengblood pressurefunctional foodginsenoside Rg3

Substanzen

Ginsenosidesginsenoside Rg3Antihypertensive AgentsPlant Extracts

Autor:innen und Institutionen

  • BTGin Co., Ltd., Daejeon 34024, Republic of Korea.
  • Department of Family Medicine, College of Medicine, Dankook University, Cheonan 31116, Republic of Korea.
  • Department of Cardiology, Dankook University Hospital, Cheonan 31116, Republic of Korea.
  • Research Institute of Clinical Medicine, Dankook University Hospital, Cheonan 31116, Republic of Korea.
  • Department of Statistics, Sookmyung Women's University, Seoul 04312, Republic of Korea.
  • Department of Nutritional Sciences, Temerty Faculty of Medicine, University of Toronto, Toronto, ON M5S 1A8, Canada.

ORCID-Profile: Hyuna Jang, Vladimir Vuksan, Hyang-Im Baek

Förderung

  • Ministry of Agriculture, Food and Rural Affairs
  • Korea Food Research Institute
  • BTGin Co., Ltd.

Zitieren

APA

Oh, J. H., Cheong, Y. S., Lim, S. H., Lee, S., Kim, J. H., Jang, H., Hour, Y., Vuksan, V., & Baek, H. I. (2026). Effects of Two Rg3-Enriched Korean Ginseng Preparations on Blood Pressure in Adults with Early-Stage Hypertension: A Randomized, Double-Blind, Placebo-Controlled Trial. Nutrients. https://doi.org/10.3390/nu18203448

Vancouver

Oh JH, Cheong YS, Lim SH, Lee S, Kim JH, Jang H, et al. Effects of Two Rg3-Enriched Korean Ginseng Preparations on Blood Pressure in Adults with Early-Stage Hypertension: A Randomized, Double-Blind, Placebo-Controlled Trial. Nutrients. 2026. doi:10.3390/nu18203448

BibTeX
@article{Oh2026,
  author = {Oh, Jin-Hwan and Cheong, Yoo-Seok and Lim, Seong-Hoon and Lee, Seong and Kim, Jin-Hee and Jang, Hyuna and Hour, Youl and Vuksan, Vladimir and Baek, Hyang-Im},
  title = {Effects of Two Rg3-Enriched Korean Ginseng Preparations on Blood Pressure in Adults with Early-Stage Hypertension: A Randomized, Double-Blind, Placebo-Controlled Trial},
  journal = {Nutrients},
  year = {2026},
  doi = {10.3390/nu18203448}
}
Kostenlos starten →